Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220017107 220007400 null 108 Palliative (P) 2014-03-17 2014-03-17 Hydroxycarbamide N N 220028558 HYDROXYCARBAMIDE
220017108 220020864 1.68 74.7 null 2017-08-02 2017-10-21 Cytarabine low (10to20mg/m2) IV/SC N N 220028560 CYTARABINE
220017109 220014076 null 43 Curative (C) 2015-03-05 2015-03-05 AML Downs HA N N 220028566 NOT MATCHED
220017110 220014077 0 34.2 Curative (C) 2014-03-22 2014-03-27 AML MyeChild 01 HD AraC N N 220028571 NOT MATCHED
220017111 220007407 null 72.6 Palliative (P) 2013-11-18 2014-01-03 ATG + Cyclophosphamide TBI Allo N N 220028590 NOT MATCHED
220017112 220007409 0 6.9 Curative (C) null 2016-01-24 null N N 220028601 NOT MATCHED
220017113 220014079 1.75 69.2 Palliative (P) 2014-09-30 2014-10-21 AML Downs haM 2 N 220028602 NOT MATCHED
220017114 220017678 1.6 85.5 Palliative (P) 2014-02-05 2014-02-11 Hydroxycarbamide N N 220028630 HYDROXYCARBAMIDE
220017115 220007413 0 46.2 Palliative (P) 2015-01-22 2015-12-20 Hydroxycarbamide N N 220028631 HYDROXYCARBAMIDE
220017116 220007414 1.04 37 Curative (C) 2013-08-12 2013-08-17 AML MyeChild 01 A Mitozantrone/Cytarabine null null 220028637 NOT MATCHED
220017117 220017679 1.81 83 Curative (C) 2017-01-21 2017-02-07 Hydroxycarbamide N N 220028644 HYDROXYCARBAMIDE
220017118 220014083 1.77 10.2 Curative (C) 2018-05-24 2018-06-29 CYCLOPHOSPHAMIDE + CYTARABINE + ETOPOSIDE null N 220028650 NOT MATCHED
220017119 220007416 1.7 76 Curative (C) 2016-11-23 2016-11-23 null 01 N 220028652 NOT MATCHED
220017120 220007417 1.78 25.55 Palliative (P) 2014-05-16 2014-05-16 APML Consolidation II ATRA,Idarubicin 2 N 220028662 NOT MATCHED
220017121 220007420 0 65.1 Palliative (P) 2015-08-22 2015-11-19 Cytarabine Low Dose 2 N 220028665 CYTARABINE
220017122 220007421 1.81 69.3 Adjuvant (A) 2018-01-22 2018-01-23 Hydroxycarbamide 2 N 220028665 HYDROXYCARBAMIDE
220017123 220017682 null null Palliative (P) 2016-07-01 2016-07-02 Cytarabine Intrathecal (any age) N N 220028677 CYTARABINE
220017124 220007424 0 null Palliative (P) 2017-04-09 2017-04-09 Hydroxycarbamide 02 N 220028683 HYDROXYCARBAMIDE
220017125 220007424 0 45.7 Palliative (P) null 2014-04-18 Cytarabine Low Dose N N 220028683 CYTARABINE
220017126 220014091 1.67 0 Palliative (P) 2016-10-18 2016-10-18 Cytarabine Low Dose N N 220028687 CYTARABINE
220017127 220014091 null 33.15 null 2015-08-10 2015-08-20 AML MyeChild 01 HD AraC null N 220028687 NOT MATCHED
220017128 220007428 1.53 null Palliative (P) null 2015-09-14 Hydroxycarbamide 99 null 220028704 HYDROXYCARBAMIDE
220017129 220017686 0 54 Curative (C) 2017-01-10 2017-04-25 AML MyeChild 01 FLA 02 N 220028706 NOT MATCHED
220017130 220007429 0 78 Curative (C) 2014-06-25 2014-07-14 Alemtuz+Fludara+Melphalan RIC MUD N N 220028709 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220017131 220007432 1.63 78.6 Palliative (P) 2015-08-23 2015-08-24 Dasatinib N N 220028709 DASATINIB
220017132 220007436 0 52.4 Curative (C) 2017-01-28 2017-01-28 Alemtuz+Fludara+Melphalan RIC MUD N N 220028725 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220017135 220021515 0 59.5 null 2015-03-25 2015-03-25 Rituximab null N 220028735 RITUXIMAB
220017136 220007438 1.77 95.5 Curative (C) 2017-09-25 2017-09-25 Alemtuz+Fludara+Melphalan RIC MUD N N 220028743 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220017137 220007439 null 61.1 Curative (C) 2018-01-16 2018-01-21 ALEMTUZUMAB + FLUDARABINE + MELPHALAN N null 220028760 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220017138 220007441 0 58 Curative (C) 2017-07-07 2017-07-07 Alemtuz+Fludara+Melphalan RIC MUD 02 N 220028763 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220017139 220007444 1.7 76.5 Disease modification (D) 2014-12-22 2014-12-22 Dasatinib 02 N 220028768 DASATINIB
220017140 220007444 0 78 Disease modification (D) 2014-07-20 2014-07-20 Alemtuz+Fludara+Melphalan RIC MUD 02 N 220028768 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220017141 220007446 1.66 95.8 Curative (C) 2014-06-16 2014-06-20 Dasatinib 2 N 220028784 DASATINIB
220017143 220007449 null 84 Disease modification (D) 2018-03-18 2018-03-18 Rituximab null N 220028792 RITUXIMAB
220017144 220007451 1.55 82.2 Disease modification (D) 2018-02-04 2018-09-05 Dasatinib 2 N 220028797 DASATINIB
220017145 220007452 0 null Disease modification (D) 2011-12-10 2013-02-22 Dasatinib 2 N 220028801 DASATINIB
220017146 220007455 null null Not known (9) 2013-09-12 2013-09-12 Dasatinib 02 null 220028803 DASATINIB
220017147 220007457 0 103.2 null 2018-02-23 2018-02-23 Dasatinib N N 220028807 DASATINIB
220017148 220007459 0 0 Palliative (P) 2018-01-01 2018-01-05 Dasatinib N N 220028812 DASATINIB
220017149 220007460 0 null Disease modification (D) 2016-11-28 2016-11-28 AML 18 TRIAL 01 null 220028814 AML18 TRIAL
220017150 220007462 null null Palliative (P) 2015-02-12 2015-02-12 Dasatinib N null 220028823 DASATINIB
220017151 220014109 null 107.5 Curative (C) 2013-02-19 2013-03-11 AML 18 TRIAL Y N 220028829 AML18 TRIAL
220017152 220007464 1.63 65.2 Disease modification (D) 2015-05-06 2017-01-17 Dasatinib 02 N 220028832 DASATINIB
220017153 220007467 null 51.3 Disease modification (D) 2015-03-27 2015-03-27 Dasatinib N N 220028861 DASATINIB
220017154 220007469 0 78.6 Adjuvant (A) 2015-12-02 2015-12-02 Dasatinib 02 N 220028863 DASATINIB
220017155 220014112 null 54.7 null 2015-01-25 2015-03-23 AML18 PILOT TRIAL N N 220028868 PILOT TRIAL
220017156 220007474 null 75.4 Curative (C) 2016-12-10 2016-12-10 ALEMTUZUMAB + FLUDARABINE + MELPHALAN N Y 220028880 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220017157 220007477 1.58 77 Disease modification (D) 2016-01-13 2016-01-13 Rituximab 02 null 220028892 RITUXIMAB
220017158 220007481 1.93 8.9 Disease modification (D) 2016-12-01 2016-12-06 Rituximab (Maintenance) N N 220028899 RITUXIMAB
220017159 220007482 null 59.6 Curative (C) 2016-02-25 2016-02-27 AML18 PILOT TRIAL 2 N 220028901 PILOT TRIAL